The study, recently published in the Archives of General Psychiatry and conducted by researchers from the University of Mississippi and the University of California-San Francisco, found that mothers who took SSRIs during the year prior to giving birth ran nearly twice the normal risk of developing autism spectrum disorder and other neurological problems.
Based on studies linking SSRIs with heart defects and a lung disorder called persistent pulmonary hypertension of the newborn, the U.S. Food and Drug Administration (FDA) issued health advisory warnings in 2005 and 2006 about the antidepressants.
According to the Mayo Clinic, health risks associated with SSRIs used during pregnancy include neural defects, abdominal development problems and limb malformation. SSRIs are the most commonly prescribed form of antidepressant medication, the Mayo Clinic states, with common brands including Zoloft, Paxil, Lexapro, Prozac and Celexa.
“Building a body of literature on SSRIs and possible birth defects is highly important,” said Candice McNabb, a drug injury attorney with the Potts Law Firm's Houston office with extensive experience in litigating complex, multidistrict litigation cases involving pharmaceuticals and other medical products.
Saturday, November 12, 2011
Drug Injury Lawyers Say Studies Suggest Links between SSRIs and Birth Defects - Yahoo! News